Log In
Print
BCIQ
Print
Print this Print this
 

BB-001

  Manage Alerts
Collapse Summary General Information
Company Bullet Biotechnology Inc.
DescriptionPersonalized active immunotherapy consisting of the idiotype protein on B cell lymphoma cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today